Author

Ze Hui Kok

Observed names: Z. Kok, Ze-Hui Kok

Institution: National Cancer Centre Singapore

Observed institutions: National University of Singapore, Singapore General Hospital, National Cancer Centre Singapore, Cancer Science Institute of Singapore

OpenAlex ID: A5015784295

A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib

2020 · Qing-Yun Chong, Ze-Hui Kok, et al. · Pharmacological Research · 106

Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulation

2021 · Kartini Asari, Wen Tian Sun, et al. · Anti-Cancer Drugs · 6

Gallic Acid Enhances the Efficacy of BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia through Inhibition of Mitochondrial Respiration and Modulation of Oncogenic Signaling Pathways

2024 · Wei Xiang, Colin Sng, et al. · International Journal of Molecular Sciences · 3

Inhibition of inflammation and senescence with azole compound C7 enables expansion of hematopoietic stem and progenitor cells

2026 · Ze Hui Kok, Lin Ming Lee, et al. · Stem Cells Translational Medicine

Multiomic Profiling of Ex Vivo Expanded Cd45 (+)cd34(bright) Cd38(-) Cd90(+) Cd49f(+)cells Reveals Novel Pathways for the Long-term Maintenance of Hematopoietic Stem and Progenitor Cells

2024 · K. Liu, Z. Kok, et al. · Cytotherapy

Enhancement of Mitochondrial Membrane Potential and Pro-Survival Pathways with Azole Compound C7 Resulting in Expansion of Hematopoietic Stem and Progenitor Cells

2023 · Kelvin YH Liu, Ze Hui Kok, et al. · Blood

Works count: 6

Citation count: 115

H-index: 3

I10-index: 1